Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma Limited has filed a disclosure with the stock exchange under Regulation 30 of the SEBI LODR Regulations, 2015. Regulation 30 filings are mandatory disclosures that listed companies must make when there are material events or developments that could impact shareholders or the stock price. The specific nature of the event being disclosed (such as a business deal, leadership change, financial update, or operational milestone) is not visible from the headline alone. Investors should refer to the full filing document on the NSE website to understand the exact details of the disclosure.
The impact on shareholders cannot be assessed without reading the full disclosure. Investors are advised to check the complete filing on the NSE/BSE corporate announcements page to understand what material information has been shared.